These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 24148129)
1. [Phenotypic screens or one stone to kill two birds: discover the target and its pharmacological regulator]. Prudent R; Soleilhac E; Barette C; Fauvarque MO; Lafanechère L Med Sci (Paris); 2013 Oct; 29(10):897-905. PubMed ID: 24148129 [TBL] [Abstract][Full Text] [Related]
2. Chemical screening in zebrafish for novel biological and therapeutic discovery. Tan JL; Zon LI Methods Cell Biol; 2011; 105():493-516. PubMed ID: 21951544 [TBL] [Abstract][Full Text] [Related]
3. [Strength and specificity of the CMBA screening platform for bioactive molecules discovery]. Barette C; Soleilhac E; Charavay C; Cochet C; Fauvarque MO Med Sci (Paris); 2015 Apr; 31(4):423-31. PubMed ID: 25958761 [TBL] [Abstract][Full Text] [Related]
4. High-throughput screening of libraries of compounds to identify CFTR modulators. Pedemonte N; Zegarra-Moran O; Galietta LJ Methods Mol Biol; 2011; 741():13-21. PubMed ID: 21594775 [TBL] [Abstract][Full Text] [Related]
5. Systematic Identification of Pharmacological Targets from Small-Molecule Phenotypic Screens. Liu X; Baarsma HA; Thiam CH; Montrone C; Brauner B; Fobo G; Heier JS; Duscha S; Königshoff M; Angeli V; Ruepp A; Campillos M Cell Chem Biol; 2016 Oct; 23(10):1302-1313. PubMed ID: 27667560 [TBL] [Abstract][Full Text] [Related]
10. Chemical genetics and drug discovery in Xenopus. Tomlinson ML; Hendry AE; Wheeler GN Methods Mol Biol; 2012; 917():155-66. PubMed ID: 22956087 [TBL] [Abstract][Full Text] [Related]
11. An in vivo multiplexed small-molecule screening platform. Grüner BM; Schulze CJ; Yang D; Ogasawara D; Dix MM; Rogers ZN; Chuang CH; McFarland CD; Chiou SH; Brown JM; Cravatt BF; Bogyo M; Winslow MM Nat Methods; 2016 Oct; 13(10):883-889. PubMed ID: 27617390 [TBL] [Abstract][Full Text] [Related]
12. 15 years of zebrafish chemical screening. Rennekamp AJ; Peterson RT Curr Opin Chem Biol; 2015 Feb; 24():58-70. PubMed ID: 25461724 [TBL] [Abstract][Full Text] [Related]
13. The why and how of phenotypic small-molecule screens. Eggert US Nat Chem Biol; 2013 Apr; 9(4):206-9. PubMed ID: 23508174 [No Abstract] [Full Text] [Related]
14. The Development of Protein Chips for High Throughput Screening (HTS) of Chemically Labeling Small Molecular Drugs. Feng Y; Wang B; Chu X; Wang Y; Zhu L Mini Rev Med Chem; 2016; 16(10):846-50. PubMed ID: 25963567 [TBL] [Abstract][Full Text] [Related]
15. Integration of RNAi and Small Molecule Screens to Identify Targets for Drug Development. Drosopoulos K; Linardopoulos S Methods Mol Biol; 2019; 1953():33-42. PubMed ID: 30912014 [TBL] [Abstract][Full Text] [Related]
17. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification. Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886 [TBL] [Abstract][Full Text] [Related]
18. Applications of chemogenomic library screening in drug discovery. Jones LH; Bunnage ME Nat Rev Drug Discov; 2017 Apr; 16(4):285-296. PubMed ID: 28104905 [TBL] [Abstract][Full Text] [Related]
19. High-throughput small-molecule screening in Caenorhabditis elegans. Rangaraju S; Solis GM; Petrascheck M Methods Mol Biol; 2015; 1263():139-55. PubMed ID: 25618342 [TBL] [Abstract][Full Text] [Related]
20. Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens. Conn PM; Smithson DC; Hodder PS; Stewart MD; Behringer RR; Smith E; Ulloa-Aguirre A; Janovick JA Pharmacol Res; 2014 May; 83():38-51. PubMed ID: 24373832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]